Maxcyte Ratios (2020-2025) | MXCT

Ratios Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 90.95%89.13%89.35%89.33%88.96%90.69%87.92%90.83%88.34%87.14%87.55%88.34%84.78%90.09%89.96%87.63%85.73%76.38%73.76%85.59%82.14%76.63%
EBT Margin -58.33%-45.82%-31.15%-109.40%-62.21%-26.44%-48.01%-35.10%-85.97%-60.45%-38.71%-126.89%-116.24%-140.57%-33.69%-83.99%-89.89%-141.56%-121.90%-98.76%-145.26%-181.81%
EBIT Margin -55.23%-42.03%-27.97%-98.12%-62.14%-24.09%-48.81%-35.89%-90.96%-72.46%-54.34%-153.66%-144.56%-174.31%-51.68%-108.23%-114.76%-172.13%-148.41%-118.33%-167.24%-207.19%
EBITDA Margin -55.23%-42.03%-27.97%-98.12%-62.14%-24.09%-48.81%-35.89%-90.96%-72.46%-54.34%-153.66%-144.56%-174.31%-51.68%-108.23%-104.39%-159.08%-148.41%-118.33%-154.44%-191.71%
Operating Margin -55.23%-42.03%-27.97%-98.12%-62.14%-24.09%-48.81%-35.89%-90.96%-72.46%-54.34%-153.66%-144.56%-174.31%-51.68%-108.23%-114.76%-172.13%-148.41%-118.33%-167.24%-207.19%
Net Margin -58.33%-45.82%-31.15%-109.40%-62.21%-26.44%-48.01%-35.10%-85.97%-60.45%-38.71%-126.89%-116.24%-140.57%-33.69%-83.99%-89.89%-141.56%-121.90%-98.76%-145.26%-181.81%
FCF Margin -22.09%-26.67%-76.22%-75.26%-21.02%-20.51%-83.66%-61.27%-88.31%-66.66%-68.59%-117.35%-111.92%0.42%-100.23%-49.17%-58.76%-91.66%-144.99%-122.68%-113.60%
Efficiency
Inventory Average 4.16M4.68M5.89M7.15M7.82M8.25M9.42M10.64M11.78M12.38M12.09M11.56M10.78M9.65M8.59M8.10M7.77M
Assets Average 185.42M280.90M287.54M290.37M288.09M286.53M284.10M276.37M268.97M267.50M263.10M254.71M250.05M244.04M234.72M224.86M216.61M
Equity Average 171.47M263.51M262.54M259.70M255.83M254.20M250.89M244.40M237.18M232.77M229.26M223.81M217.28M209.78M202.83M195.07M185.50M
Invested Capital 33.23M78.82M264.12M262.90M262.18M257.22M254.43M253.97M247.82M240.98M233.38M232.17M226.36M221.26M213.30M206.25M199.41M190.72M180.28M
Asset Utilization Ratio 0.170.120.140.140.150.150.150.150.140.150.170.180.180.160.160.160.16
Leverage & Solvency
Interest Coverage Ratio -17.27-10.80-8.49-8.59-334.64-8.45-66.48-613.70
Debt to Equity 0.15
Debt Ratio 0.09
Equity Ratio 0.640.850.950.930.900.890.890.890.880.890.870.870.880.880.860.860.870.870.84
Times Interest Earned -17.27-10.80-8.49-8.59-334.64-8.45-66.48-613.70
Valuation
Enterprise Value -34.76M-73.39M-255.89M-255.04M-246.28M-240.89M-232.89M-227.34M-224.65M-216.11M-190.24M-168.29M-157.51M-157.33M-153.83M-154.48M-138.27M-126.56M-105.73M
Return Ratios
Return on Sales -0.58%-0.46%-0.31%-1.09%-0.62%-0.26%-0.48%-0.35%-0.86%-0.60%-0.39%-1.27%-1.16%-1.41%-0.34%-0.84%-0.90%-1.42%-1.22%-0.99%-1.45%-1.82%
Return on Capital Employed -0.09%-0.07%-0.06%-0.07%-0.09%-0.10%-0.14%-0.15%-0.19%-0.19%-0.19%-0.19%-0.20%-0.22%-0.23%-0.25%-0.27%
Return on Assets -0.09%-0.07%-0.06%-0.07%-0.08%-0.08%-0.11%-0.12%-0.14%-0.14%-0.14%-0.14%-0.14%-0.17%-0.18%-0.20%-0.21%
Return on Equity -0.10%-0.07%-0.06%-0.08%-0.09%-0.09%-0.12%-0.13%-0.16%-0.16%-0.16%-0.16%-0.16%-0.20%-0.21%-0.23%-0.25%